Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 1-20 of 127

Title Wave Anticipated publication date Referral date Process
Arrythmias - ICDs & Heart failure - cardiac resynchronisation [ID481] R Sep 2013 MTA
Arthritis of the hip (end stage) - hip replacement (total) and surface replacement (Rev TA2, TA44) [ID540] R Dec 2013 MTA
Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201) [ID482] R Nov 2012 MTA
Atrial fibrillation - clopidogrel (in combination with aspirin) (suspended) [ID95] 21 TBC Jul 2009 STA
Atrial fibrillation - idraparinux sodium [ID375] 12 TBC Nov 2005 STA
Atrial fibrillation - vernakalant [ID454] 26 TBC May 2011 STA
Atrial fibrillation - ximelagatran (suspended) [ID376] 9 TBC Oct 2000 MTA
Bipolar disorder (children) - aripiprazole [ID305] 22 Feb 2013 Jan 2010 STA
Bone loss (therapy-induced) in non-metastatic breast cancer - denosumab (suspended) [ID83] 20 TBC Apr 2009 STA
Bone metastases from solid tumours - denosumab [ID81] 21 Jun 2012 Apr 2009 MTA
Bowel function - methylnaltrexone [ID2] 18 Nov 2013 Jul 2008 STA
Breast cancer (advanced and/or metastatic) - sunitinib (in combination with capecitabine) - suspended [ID319] 19 TBC Mar 2009 STA
Breast cancer (advanced or metastatic) - lapatinib (suspended) [ID20] 13 TBC Dec 2006 STA
Breast cancer (advanced or metastatic) hormone-sensitive - lapatinib (discontinued) [ID115] 15 TBC Dec 2007 STA
Breast cancer (ErbB2 HER2, metastatic) - lapatinib (with paclitaxel, 1st line) [ID517] 25 TBC Nov 2011 STA
Breast cancer (first line treatment) - sunitinib (in combination with a taxane) (suspended) [ID58] 19 TBC Mar 2009 STA
Breast cancer (HER2 negative, metastatic) - bevacizumab (2nd line) [ID488] 27 TBC Nov 2011 STA
Breast cancer (locally advanced or metastatic) - ixabepilone [ID377] 15 TBC Dec 2007 STA
Breast cancer (metastatic hormone-receptor) - lapatinib and trastuzumab (with aromatase inhibitor) [ID344] 0 Jun 2012 Oct 2008 MTA
Breast cancer (metastatic) - bevacizumab (1st line, with capecitabine) [ID54] 19 Aug 2012 Nov 2008 STA

This page was last updated: 25 May 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright @ 2012 National Institute for Health and Clinical Excellence. All rights reserved.